Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.

Pelletier J, Bruening W, Li FP, Haber DA, Glaser T, Housman DE.

Nature. 1991 Oct 3;353(6343):431-4.

PMID:
1654525
2.

The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient.

Pritchard-Jones K, Renshaw J, King-Underwood L.

Hum Mol Genet. 1994 Sep;3(9):1633-7.

PMID:
7833922
3.

Genotype/phenotype correlations in Wilms' tumor.

Huff V.

Med Pediatr Oncol. 1996 Nov;27(5):408-14.

PMID:
8827067
4.

Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.

Gessler M, König A, Arden K, Grundy P, Orkin S, Sallan S, Peters C, Ruyle S, Mandell J, Li F, et al.

Hum Mutat. 1994;3(3):212-22.

PMID:
8019557
5.

Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.

Park S, Tomlinson G, Nisen P, Haber DA.

Cancer Res. 1993 Oct 15;53(20):4757-60.

6.

Molecular analysis of aniridia patients for deletions involving the Wilms' tumor gene.

Drechsler M, Meijers-Heijboer EJ, Schneider S, Schurich B, Grond-Ginsbach C, Tariverdian G, Kantner G, Blankenagel A, Kaps D, Schroeder-Kurth T, et al.

Hum Genet. 1994 Oct;94(4):331-8.

PMID:
7927324
7.

Homozygous inactivation of WT1 in a Wilms' tumor associated with the WAGR syndrome.

Gessler M, König A, Moore J, Qualman S, Arden K, Cavenee W, Bruns G.

Genes Chromosomes Cancer. 1993 Jul;7(3):131-6.

PMID:
7687865
8.

Inherited WT1 mutation in Denys-Drash syndrome.

Coppes MJ, Liefers GJ, Higuchi M, Zinn AB, Balfe JW, Williams BR.

Cancer Res. 1992 Nov 1;52(21):6125-8.

9.

Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.

Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, et al.

Cell. 1991 Oct 18;67(2):437-47.

PMID:
1655284
10.

Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.

Brown KW, Watson JE, Poirier V, Mott MG, Berry PJ, Maitland NJ.

Oncogene. 1992 Apr;7(4):763-8.

PMID:
1314370
11.

The role of Wilms' tumor genes.

Hirose M.

J Med Invest. 1999 Aug;46(3-4):130-40. Review.

PMID:
10687307
12.

Molecular genetics of Wilms' tumour.

Tay JS.

J Paediatr Child Health. 1995 Oct;31(5):379-83. Review.

PMID:
8554853
13.

Splicing of exon 5 in the WT1 gene is disrupted in Wilms' tumour.

Simms LA, Algar EM, Smith PJ.

Eur J Cancer. 1995 Dec;31A(13-14):2270-6. Erratum in: Eur J Cancer 1996 Jan;32A(1):185.

PMID:
8652255
14.

Role of the WT1 gene in Wilms' tumour.

Haber DA, Housman DE.

Cancer Surv. 1992;12:105-17. Review.

PMID:
1322241
15.

WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.

Haber DA, Buckler AJ.

New Biol. 1992 Feb;4(2):97-106. Review.

PMID:
1313285
16.

Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.

Grubb GR, Yun K, Reeve AE, Eccles MR.

Oncogene. 1995 Apr 20;10(8):1677-81.

PMID:
7731725
17.

Identical genetic changes in different histologic components of Wilms' tumors.

Zhuang Z, Merino MJ, Vortmeyer AO, Bryant B, Lash AE, Wang C, Deavers MT, Shelton WF, Kapur S, Chandra RS.

J Natl Cancer Inst. 1997 Aug 6;89(15):1148-52.

PMID:
9262253
18.

Expression of the Wilms' tumor gene WT1 in the murine urogenital system.

Pelletier J, Schalling M, Buckler AJ, Rogers A, Haber DA, Housman D.

Genes Dev. 1991 Aug;5(8):1345-56.

19.

The candidate Wilms' tumour gene is involved in genitourinary development.

Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, et al.

Nature. 1990 Jul 12;346(6280):194-7.

PMID:
2164159
20.

Germline WT1 mutations in Wilms' tumor patients: preliminary results.

Li FP, Breslow NE, Morgan JM, Ghahremani M, Miller GA, Grundy PE, Green DM, Diller LR, Pelletier J.

Med Pediatr Oncol. 1996 Nov;27(5):404-7.

PMID:
8827066

Supplemental Content

Support Center